Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Merck
Boehringer Ingelheim
AstraZeneca
Express Scripts
UBS
Argus Health
Queensland Health
Cantor Fitzgerald

Generated: May 20, 2018

DrugPatentWatch Database Preview

RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ravocaine And Novocain W/ Neo-cobefrin patents expire, and when can generic versions of Ravocaine And Novocain W/ Neo-cobefrin launch?

Ravocaine And Novocain W/ Neo-cobefrin is a drug marketed by Eastman Kodak and is included in one NDA.

The generic ingredient in RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN is levonordefrin; procaine hydrochloride; propoxycaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; procaine hydrochloride; propoxycaine hydrochloride profile page.
Summary for RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN
Drug patent expirations by year for RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN

US Patents and Regulatory Information for RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eastman Kodak RAVOCAINE AND NOVOCAIN W/ NEO-COBEFRIN levonordefrin; procaine hydrochloride; propoxycaine hydrochloride INJECTABLE;INJECTION 008592-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
UBS
Federal Trade Commission
Citi
Cerilliant
US Department of Justice
Harvard Business School
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.